Skip to main content
. 2023 Oct 9;208(12):1316–1327. doi: 10.1164/rccm.202306-1036OC

Figure 3.


Figure 3.

Proportion of patients with a ⩾20% reduction in AHI4 from baseline (A) and with apnea–hypopnea index (⩾4% desaturation criterion for hypopneas) of fewer than 10 events per hour during treatment (B) in the different treatment arms. Error bars in B indicate 95% confidence intervals. AHI4 = apnea–hypopnea index (⩾4% desaturation criterion for hypopneas); Ato75 = atomoxetine 75 mg.